Arrowstreet Capital’s GoHealth GOCO Stock Holding History

Arrowstreet Capital’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,262	Closed	-$2.4M	–	2380
2020 Q3	$2.4M	Buy	+12,262	New	+$2.95M	﹤0.01%	1488

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Arrowstreet Capital's GOCO Position: Q4 2020 in Review

Arrowstreet Capital sold out of GoHealth (GOCO) in Q4 2020, closing a stake of 12,262 shares — an estimated $2.4M sold.

Arrowstreet Capital first reported a position in GOCO in Q3 2020 and held it in 1 quarter. The position peaked at $2.4M in Q3 2020. 99 funds tracked by Wall St. Rank hold GOCO as of Q4 2020.

Arrowstreet Capital reported no remaining GoHealth position as of Q4 2020 after selling out during the quarter.
Arrowstreet Capital sold 12,262 GoHealth shares in Q4 2020, an estimated $2.4M.
Arrowstreet Capital first reported a position in GoHealth in Q3 2020 and held it in 1 quarter.
Arrowstreet Capital's GoHealth position peaked at $2.4M in Q3 2020.
99 funds tracked by Wall St. Rank held GoHealth as of Q4 2020.

Based on Arrowstreet Capital's 13F filing for Q4 2020, filed 12 Feb 2021.